Ehave Provides Progress Update on its HPPD Study with University of Melbourne
02 févr. 2023 08h30 HE
|
Ehave
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to...
FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder
15 déc. 2022 08h00 HE
|
Ehave
MIAMI, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, announced today...
Ehave Shareholder from CEO Ben Kaplan and Corporate Update
07 déc. 2022 08h00 HE
|
Ehave
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a...
Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022
03 juin 2022 09h00 HE
|
Ehave
MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will accept...
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research
01 juin 2022 09h00 HE
|
Ehave
AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in the clinicGenetic test kit evaluates an...
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ
23 mai 2022 09h00 HE
|
Ehave
MIAMI, May 23, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today that its Mycotopia Therapies (OTC: TPIA)...
Ehave Announces MetaHealthU Will Enter The Market With A Focus On HPPD
19 avr. 2022 08h30 HE
|
Ehave
MIAMI, April 19, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its MetaHealthU mobile application...
Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses
03 mars 2022 08h30 HE
|
Ehave
Agreement with Heally adds doctors, licensed psychotherapists and registered nurses to the KetaDASH platformWith the opening of KetaDASH, Ehave builds momentum for the psychedelic renaissance in the...
Ehave, Inc. Licensing Partner Vastmindz Seen By Millions Of Viewers On Unicorn Hunter
24 févr. 2022 08h30 HE
|
Ehave
Ehave has licensed AI technology from Vastmindz for MetaHealthU.in 2022, Ehave plans to monetize the AI technology it licensed from Vastmindz to expand the Ehave Dashboard in the MetaHealthU offering...
Ehave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market
15 févr. 2022 08h30 HE
|
Ehave
KetaDASH will provide ketamine therapy for the treatment of mental health disordersKetaDASH is a managed service organization focused on the psychedelic sector with the mission of helping physicians...